Workup of Bradycardia in Adults
Begin by establishing whether the bradycardia is symptomatic and correlating symptoms with documented bradycardia—this is the gold standard for determining clinical significance and need for intervention 1.
Initial Evaluation Framework
1. Assess for Reversible Causes (Class I Recommendation)
Immediately evaluate and treat reversible etiologies 1:
- Medications: Beta-blockers, calcium channel blockers, digoxin, antiarrhythmics
- Acute coronary syndrome/MI: Check troponin, obtain 12-lead ECG
- Electrolyte abnormalities: Particularly hyperkalemia
- Metabolic disturbances: Hypothyroidism (TSH), hypothermia
- Infections: Lyme disease, endocarditis
- Sleep apnea: Screen if nocturnal bradycardia present (symptoms include snoring, daytime somnolence, witnessed apneas) 2
Critical pitfall: Nocturnal bradycardia alone is NOT an indication for permanent pacing—always screen for sleep apnea first 2.
2. Establish Symptom-Rhythm Correlation
The cornerstone of bradycardia workup is documenting temporal correlation between symptoms and heart rate 1, 3. Do not base treatment decisions solely on arbitrary heart rate cutoffs or pause durations 3.
Key symptoms to correlate:
- Syncope or presyncope
- Lightheadedness or dizziness
- Dyspnea on exertion from chronotropic incompetence
- Chronic fatigue
- Chest pain
3. Diagnostic Testing Algorithm
12-Lead ECG (essential first step) 4:
- Identifies sinus node dysfunction vs. AV block
- Left bundle branch block (LBBB) markedly increases likelihood of structural heart disease and LV systolic dysfunction 2
- Assesses for acute MI, conduction abnormalities
Echocardiography 2:
- Indicated when LBBB present
- Screen for structural heart disease and LV systolic dysfunction
- Most appropriate initial imaging test
Ambulatory Monitoring (progressive approach) 1:
- 24-hour Holter: For frequent symptoms
- Extended monitoring (14-30 days): For less frequent symptoms
- Implantable cardiac monitor (ICM): Superior to conventional testing for unexplained syncope when initial workup nondiagnostic 1
- Most effective strategy for obtaining clinical diagnosis in syncope patients
- Many diagnoses are bradycardia-mediated (high-grade AV block, sinus node dysfunction, neurocardiogenic syncope)
Exercise stress testing:
- Assess chronotropic competence
- Evaluate for exertional symptoms
4. Electrophysiology Study (EPS)
May be considered (Class IIb) only after noninvasive evaluation is nondiagnostic 1:
- Reserved for selected patients with suspected bradycardia
- Higher yield in patients with:
- Structural heart disease (CAD, hypertension)
- Abnormal baseline ECG (bundle branch block, prior MI)
- Unexplained syncope with trauma and high pretest probability for conduction disease (e.g., LBBB)
- Not a first-line test—most bradycardia causes can be established noninvasively 1
Key Diagnostic Principles
For Sinus Node Dysfunction 2:
- No established minimum heart rate or pause duration mandates pacing
- Symptom-rhythm correlation is paramount
- Age-dependent progressive fibrosis is most common etiology
For AV Block 2:
- Mobitz II second-degree, high-grade, or third-degree AV block requires permanent pacing regardless of symptoms (unless reversible/physiologic cause)
- All other AV block types: pacing only if symptomatic (absent progressive conditions)
Distinguishing Intrinsic vs. Vagal-Mediated Bradycardia 5:
- Intrinsic: Conduction system disease requiring intervention
- Vagal-mediated: Benign phenomenon, avoid unnecessary pacing
- Correct identification is imperative to prevent inappropriate device implantation
Common Pitfalls to Avoid
- Do not pace nocturnal bradycardia without evaluating for sleep apnea 2
- Do not use arbitrary heart rate thresholds to determine need for intervention 3
- Do not administer atropine to heart transplant patients (Class III: Harm) 1
- Do not overlook structural heart disease when LBBB is present 2
- Do not proceed to EPS before exhausting noninvasive monitoring options 1